In recent years,versatile functionalized mesoporous silica nanoparticles (MSNs)-based stimuliresponsive controlled-release systems have been investigated [1,2].However,mutual restrictions between pore size and particle size of MSNs limit their further applications,especially in the development of controlled release systems ofbiomacromolecules,such as insulin,antigen,and siRNA[2].